首页> 外文期刊>Clinical ophthalmology >Stenotrophomonas maltophilia endophthalmitis following cataract surgery: clinical and microbiological results
【24h】

Stenotrophomonas maltophilia endophthalmitis following cataract surgery: clinical and microbiological results

机译:白内障手术后嗜麦芽窄食单胞菌性眼内炎:临床和微生物学结果

获取原文
           

摘要

Background: Stenotrophomonas maltophilia is a Gram-negative organism known to cause opportunistic infections. It is a rare source of endophthalmitis, often in the setting of trauma, but has been reported following cataract extraction. The purpose of this study was to evaluate antimicrobial sensitivities, clinical characteristics, and treatment outcomes in patients with endophthalmitis caused by S. maltophilia following cataract extraction. Methods: A retrospective case review of records from January 1, 1990 to June 30, 2010 was performed at the Bascom Palmer Eye Institute. Results: Eight cases of S. maltophilia endophthalmitis were identified following cataract surgery. Initial visual acuity ranged from 20/200 to light perception. Time to diagnosis with cultures was 2–118 days. Patients received either intravitreal tap and inject (n = 5) or pars plana vitrectomy with intravitreal antibiotic injections (n = 3). All patients had vitreous or anterior chamber cultures positive for S. maltophilia. Seven of seven isolates tested were found to be sensitive to ceftazidime. Seven of eight isolates were sensitive to polymyxin B, six of eight isolates were sensitive to amikacin, and five of the seven isolates tested were sensitive to ciprofloxacin. Two of four tested isolates were sensitive to trimethoprim-sulbactam. All eight isolates were resistant to gentamicin and seven of the seven tested isolates were resistant to imipenem. All patients received intravitreal ceftazidime as part of the initial treatment regimen. Final visual acuity ranged from 20/25 to 4/200. Conclusion: S. maltophilia endophthalmitis is a rare source of endophthalmitis following cataract surgery. A case series of eight independent patients is reported, along with antibiotic resistance profiles and clinical outcomes. Isolates showed sensitivity to ceftazidime, amikacin, and polymyxin, with variable sensitivity to other antibiotics, therefore differing from previous reports.
机译:背景:嗜麦芽窄食单胞菌是一种革兰氏阴性生物,已知会引起机会性感染。它是眼内炎的罕见来源,通常发生在外伤的情况下,但有报道称白内障摘除后会发生眼内炎。这项研究的目的是评估白内障摘除术后由嗜麦芽孢杆菌引起的眼内炎患者的抗菌敏感性,临床特征和治疗效果。方法:在Bascom Palmer眼科研究所对1990年1月1日至2010年6月30日的记录进行回顾性病例回顾。结果:白内障手术后鉴定出八例嗜麦芽肿性眼炎。初始视敏度从20/200到光线感知。诊断为文化的时间为2至118天。患者接受玻璃体内轻击和注射(n = 5)或玻璃体切除术联合玻璃体内抗生素注射(n = 3)。所有患者的玻璃体或前房培养的嗜麦芽孢杆菌都呈阳性。发现测试的七个分离株中有七个对头孢他啶敏感。八株分离株中有七株对多粘菌素B敏感,八株分离株中有六株对丁胺卡那霉素敏感,七种分离株中有五株对环丙沙星敏感。四个测试菌株中有两个对甲氧苄氨舒巴坦敏感。所有八个分离株均对庆大霉素具有抗性,在七个测试分离株中有七个对亚胺培南具有抗性。所有患者均接受玻璃体内头孢他啶作为初始治疗方案的一部分。最终视力范围为20/25至4/200。结论:嗜麦芽孢杆菌眼内炎是白内障手术后罕见的眼内炎来源。报告了一个病例系列,包括八名独立患者,以及抗生素耐药性和临床结局。分离株显示出对头孢他啶,丁胺卡那霉素和多粘菌素的敏感性,对其他抗生素的敏感性不同,因此与以前的报道有所不同。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号